Molecular Medicine Partnership Unit

The Molecular Medicine Partnership Unit (MMPU) is an alliance between the European Molecular Biology Laboratory (EMBL) and the Medical Faculty of the University of Heidelberg. Its primary aim is to uncover the molecular basis of disease and to speed the transformation of biomedical discoveries into personalized medicine strategies.

Founded in 2002, the MMPU currently comprises seven inter-disciplinary research teams. The MMPU is co-directed by Prof. Andreas Kulozik from the Angelika-Lautenschläger Hospital for Children and Adolescents at the University of Heidelberg, by Prof. Matthias Hentze and Dr. Jan Korbel from EMBL, and is housed in the Otto-Meyerhof-Research Center on the Medical Campus of the University of Heidelberg, Germany.

EMBL campus in Heidelberg. Photo: Photolab EMBL
Otto-Meyerhof-Research Center in Heidelberg. Photo: Medienzentrum Universitätsklinikum Heidelberg

Research themes

Research themes place emphasis on common diseases as well as on rare diseases with a particular medical need.

In 2020 more than 100 international scientists work on the following seven research themes:

  • ‘Diseases of mRNA metabolism’, headed by Andreas Kulozik and Matthias Hentze
  • ‘Iron homeostasis in health and disease’, headed by Martina Muckenthaler and Matthias Hentze.
  • ‘Chronic Pain and Homeostasis’ headed by Rohini Kuner,Theodore Alexandrov, Robert Prevedel and Jan Siemens.
  • ‘Molecular Pediatric Oncology’ headed by Jan Korbel and Andreas Kulozik.
  • ‘Systems Medicine of Cancer Drugs’ headed by Sascha Dietrich and Wolfgang Huber.
  • ‘Stem Cell–Niche Networks in Ageing and Disease’ headed by Caroline Pabst, Judith Zaugg, Anthony D. Ho and Carsten Müller–Tidow.
  • ‘Chronic Kidney Diseases’ headed by Christoph Merten, Rainer Pepperkok and Julio Saez-Rodriguez.

Selected recent publications
gollark: ++exec -L c-gcc```cint main(int apiohazard, char* *apioform) { char *buf = (char*)"hello apiohazards\0\0\0\0"; printf("out: %s", buf); return 0;}```
gollark: It probably won't be because then C people would go "BUT MY 1µs OF PERFORMANCE!".
gollark: ++exec -L c-gcc```cchar[1024] buf;int main(int apiohazard, char* *apioform) {// char *buf = (char*)"APIONODE\0\0\0\0"; printf("out: %s", buf); return 0;}```
gollark: I see.
gollark: ++exec -L c-gcc```cint main(int apiohazard, char* *apioform) { char *buf = (char*)"APIONODE\0\0\0\0"; printf("out: %s", buf); return 0;}```

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.